Abstract:Objective: One of the disadvantages of using CSC (calcium sulfate cement) in vivo is its weak osteogenic activity. Thus composite materials based on CSC have been recently studied. Silica-based mesoporous material (SBA-15) shows great potential for biological applications because of its functionalized surfaces and biocompatibility. We assumed that blending SBA-15 into CSC could improve the osteogenic activity of the CSC. Methods: SBA-15 was blended into CSC powder at a mass ratio of 5%, 10% and 20% to make a CSC/SBA composite. Four groups including CSC (pure CSC), CSC-5S (5% mass ratio), CSC-10S (10% mass ratio) and CSC-20S (20% mass ratio) group were designed. The cell adherence was assessed using the cell counting. The cell proliferation was determined by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The osteogenic differentiation was evaluated using alkaline phosphatase (ALP) staining, alizarin red staining analysis, and the expression levels of osteogenic related genes, mainly ALP, collagen I (COL1), osteopontin and osteocalcin. An in vivo animal study was performed using the radius bone defect in a rabbit model. The micro computed tomography (CT) and histological evaluation were used to investigate bone formation. Results: The number of adhered cells on the CSC-10S and CSC-20S surface was higher than that on CSC and CSC-5S surface. The relative cell proliferation rate in CSC/SBA group was higher than that in CSC group. Compared with CSC and CSC-5S group, ALP staining in CSC-10S and CSC-20S group was increased. Alizarin red staining in the different CSC/SBA groups was higher than that in the CSC group. Higher expression levels of osteogenic differentiation-related genes were seen in cells grown on CSC/SBA composite. Micro CT and histological evaluation confirmed that CSC/SBA composite improved the efficiency of new bone formation in the bone defect. The above osteogenic activities were enhanced with increased mass ratio of SBS-15 in CSC/SBA composite. Conclusion: Incorporation of SBA-15 into CSC could greatly improve the osteogenic activity of CSC, implying the CSC/SBA composite are more beneficial to the bone repairing than pristine CSC.

Controlled and Sustained Drug Release Performance of Calcium Sulfate Cement Porous TiO2 Microsphere Composites.

Evaluation of Sustained Drug Release Performance and Osteoinduction of Magnetron-Sputtered Tantalum-Coated Titanium Dioxide Nanotubes.

Preparation and physical characterization of calcium sulfate cement/silica-based mesoporous material composites for controlled release of BMP-2

In vitro sustained drug release of large-pore calcium phosphate cement and chitosan microsphere ;composites

The Preparation and Study on Properties of Calcium Sulfate Bone Cement Combined Tuning Silk Fibroin Nanofibers and Vancomycin-Loaded Silk Fibroin Microspheres.

Hierarchical antibiotic delivery system based on calcium phosphate cement/montmorillonite-gentamicin sulfate with drug release pathways

Calcium Sulfate Cement Combined With Silica-Based Mesoporous Material For Bone Regeneration: In Vitro And In Vivo Study

Calcium Phosphate/chitosan Composite Scaffolds for Controlled in Vitro Antibiotic Drug Release.

Influences of Doping Mesoporous Magnesium Silicate on Water Absorption, Drug Release, Degradability, Apatite-Mineralization and Primary Cells Responses to Calcium Sulfate Based Bone Cements.

Salmon Calcitonin-Loaded Plga Microspheres/Calcium Phosphate Cement Composites For Osteoblast Proliferation

[Modification of calcium sulfate bone cement by gentamicin and oxygen-carboxymethylated chitosan].

In Vitro Degradability, Bioactivity And Primary Cell Responses To Bone Cements Containing Mesoporous Magnesium-Calcium Silicate And Calcium Sulfate For Bone Regeneration

Self-expanding PMMA composite bone cement with sustained release of gentamicin sulfate and alendronate using water absorption pathways

Synthesis and Drug Delivery Property of Calcium Phosphate Cement with Special Crystal Morphology

Controlled degradation of chitosan-coated strontium-doped calcium sulfate hemihydrate composite cement promotes bone defect repair in osteoporosis rats

Promotion of in Vivo Degradability, Vascularization and Osteogenesis of Calcium Sulfate-Based Bone Cements Containing Nanoporous Lithium Doping Magnesium Silicate

A Bioactive Degradable Composite Bone Cement Based on Calcium Sulfate and Magnesium Polyphosphate

Improved Injectability and in Vitro Degradation of a Calcium Phosphate Cement Containing Poly(lactide-Co-glycolide) Microspheres.

Dopant-dependent tailoring of physicochemical and biological properties of calcium silicate bone cements.

A Comprehensive Study of Osteogenic Calcium Phosphate Silicate Cement: Material Characterization and In Vitro/In Vivo Testing.

In Vitro Evaluation of Gentamicin Release from A Bioactive Tricalcium Silicate Bone Cement